Lawmaker Says Mylan's Lobbying Opened The Door For EpiPen Scrutiny
"You've been in these hallways to ask us to make people buy your stuff," U.S. Rep. Mick Mulvaney said.By Stephanie Liebergen | September 21, 2016
"You get what you deserve," said Rep. Mick Mulvaney of South Carolina.
Mylan CEO Heather Bresch got a tongue-lashing from Congress. Lawmakers grilled Bresch for hours, accusing her company of jacking up the price of EpiPens to make a bigger profit.
Bresch testified that a two-pack of pens costs $608. Mylan's revenue from that pack is $274, and Bresch asserts Mylan's profits are $100 after compensating for the cost to make the pens.